Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 5/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | VHL | P40337 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.38 |
| ▸ | CDK2 | P24941 | 2/20 | 0.38 |
| ▸ | ELOC | Q15369 | 1/20 | 0.38 |
| ▸ | ELOB | Q15370 | 1/20 | 0.38 |
| ▸ | GSK3B | P49841 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL845390 | 0.94 | VHL (0.48) | VHLLMNAALDH1A1TSHRCCNE1 | |
| SCHEMBL13272496 | 0.94 | VHL (0.40) | CNR2CNR1VHLLMNAALDH1A1 | |
| SCHEMBL844966 | 0.89 | VHL (0.44) | VHLALDH1A1TSHRCCNE1CDK2 | |
| SCHEMBL13272504 | 0.89 | VHL (0.44) | VHLALDH1A1TSHRCCNE1CDK2 | |
| SCHEMBL844965 | 0.89 | VHL (0.44) | VHLLMNAALDH1A1TSHRCCNE1 | |
| SCHEMBL845607 | 0.88 | VHL (0.43) | VHLLMNAALDH1A1TSHRCCNE1 | |
| SCHEMBL845253 | 0.88 | VHL (0.43) | VHLLMNAALDH1A1TSHRCCNE1 | |
| SCHEMBL13272388 | 0.88 | VHL (0.43) | VHLLMNAALDH1A1TSHRCCNE1 | |
| SCHEMBL845719 | 0.85 | VHL (0.41) | VHLLMNAALDH1A1TSHRCCNE1 | |
| SCHEMBL845255 | 0.81 | CYP2C9 (0.47) | CNR2CNR1LMNAALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143288-B2 | Inhibitors of HCV replication | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| US-8143288-B2 | Inhibitors of HCV replication | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| EP-1893573-B1 | INHIBITORS OF HCV REPLICATION | BRISTOL MYERS SQUIBB CO (US) | 2010-07-21 | — | — | EP | disclosed |